NEW YORK, Aug. 24, 2023 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Apellis Pharmaceuticals, Inc. (“Apellis” or the “Company”) (NASDAQ: APLS) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Apellis investors who were…